# A Step Forward for Unraveling the Immune Mechanisms and Tools for Tuberculosis Spectrum Management

> **NCT07735754** · — · NOT_YET_RECRUITING · sponsor: **Irene Latorre Rueda** · enrollment: 940 (estimated)

## Conditions studied

- Tuberculosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07735754
- **Lead sponsor:** Irene Latorre Rueda
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-09
- **Final completion:** 2029-12
- **Target enrollment:** 940 (ESTIMATED)
- **Last updated:** 2026-07-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07735754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07735754, "A Step Forward for Unraveling the Immune Mechanisms and Tools for Tuberculosis Spectrum Management". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07735754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
